Epidemiology of erectile dysfunction

International Journal of Impotence Research

Volumn 15, Issue 1, 2003, Pages 63-71

  Kubin, M ^a   Wagner, G ^b   Fugl Meyer, A R ^c  

^a BAYER AG   (Germany)

^b Rigshospitalet   (Denmark)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Distress; Erectile dysfunction; Prevalence; Risk factors

Indexed keywords

ANGIOTENSIN ANTAGONIST; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTROGEN; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; OPIATE; PROSTAGLANDIN INHIBITOR; THIAZIDE DIURETIC AGENT; TRANQUILIZER;

ADULT; AGED; CARDIOVASCULAR DISEASE; DEPRESSION; DIABETES MELLITUS; DISEASE SEVERITY; DISTRESS SYNDROME; EPIDEMIOLOGICAL DATA; ERECTILE DYSFUNCTION; HUMAN; IATROGENIC DISEASE; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MOOD DISORDER; NEUROLOGIC DISEASE; PATIENT SATISFACTION; PREVALENCE; PRIORITY JOURNAL; PROSTATECTOMY; QUALITY OF LIFE; REVIEW; RISK FACTOR; SEXUAL BEHAVIOR; VARIANCE; VASCULAR DISEASE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; COMORBIDITY; DEPRESSION; EUROPE; HUMANS; IATROGENIC DISEASE; IMPOTENCE; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; UNITED STATES;

EID: 0037300054     PISSN: 09559930     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijir.3900949     Document Type: Review

References (68)

1. Lewis R, Hatzichristou D, Lauman E, McKinley J. Epidemiological and natural history of erectile dysfunction; risk factors including iatrogenic and aging. In: Jardin A, Wagner G, Khoury S, Giuliano F, Padma-Nathan H, Rosen R (eds). Erectile Dysfunction. Plymbridge Distributors Ltd, Plymouth PL 6 7PY, United Kingdom, 2000, pp 19-51.
2. Simons JS, Carey MP. Prevalence of sexual dysfunctions: results from a decade of research. Arch Sex Behav 2001; 30: 177-219.
3. NIH Consensus Development Panel on Impotence. Impotence. NIH Consensus Development Panel on Impotence. Am Med Assoc 1993; 270: 83-90.
4. Krane RJ, Goldstein I, Saenz de Tejada I. Impotence. N Engl J Med 1989; 321: 1648-1659.
5. Fugl-Meyer AR, Branholm IB, Fugl-Meyer KS. Happiness and domain-specific life satisfaction in adult northern Swedes. Clin Rehabili 1991; 5: 25-33.
6. Fugl-Meyer AR, Lodnert G, Branholm IB, Fugl-Meyer KS. On life satisfaction in male erectile dysfunction. Int J Impot Res 1997; 9: 141-148.
7. Fugl-Meyer KS. Chapter 12 Sex in Sweden: On the Swedish Sexual Life. The National Institute of Public Health. Stockholm, 1998, pp 218-234.
8. Fendrick AM. Access to innovative treatment of erectile dysfunction: clinical, economic, and quality-of-life considerations. Am J Manage Care 2000; 6 (Suppl 12): S632-S638.
9. Tan HL. Economic cost of male erectile dysfunction using a decision analytic model: for a hypothetical managed-care plan of 100,000 members. Pharmacoeconomics 2000; 17: 77-107.
10. Stolk EA et al. Cost utility analysis of sildenafil compared with papaverine-phentolamine injections. BMJ 2000; 320: 1165-1168.
11. Smith KJ, Roberts MS. The cost-effectiveness of sildenafil. Ann Intern Med 2000; 132: 933-937.
12. Kinsey AC. Sexual Behaviour in the Human Male. W B Saunders: Philadelphia, 1948.
13. Spector IP, Carey MP. Incidence and prevalence of the sexual dysfunctions: a critical review of the empirical literature. Arch Sex Behav 1990; 19: 389-408.
14. Feldman HA et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54-61.
15. Rosen RC et al. The international index of erectile function (IIEF): a multidimensional scale for assessments of erectile dysfunction. Urology 1997; 49: 822-830.
16. Fugl-Meyer AR, Fugl-Meyer K. Sexual disabilities, problems and satisfaction in 18-74 year old Swedes. Scand J Sexol 1999; 2: 79-105.
17. Béjin A. The epidemiology of premature ejaculation and of its association with erectile dysfunction. Adrologie 1999; 9: 211-225.
18. Solstad K, Hertoft P. Frequency of sexual problems and sexual dysfunction in middle-aged Danish men. Arch Sex Behav 1993; 22: 51-58.
19. Johannes CB et al. Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study. J Urol 2000; 163: 460-463.
20. Ventegodt S. Sex and the quality of life in Denmark. Arch Sex Behav 1998; 27: 295-307.
21. Kontula O, Haavio-Mannila E. Sexual Pleasures. Enhancement of Sex Life in Finland, 1971-1992. Dartmouth Publishing Company: Aldershot, 1995.
22. Malmsten UG, Milson I, Molander U, Norlen LJ. Urinary incontinence and lower urinary tract symptoms: an epidemiological study of men aged 45 to 99 years. J Urol 1997; 158: 1733-1737.
23. Braun M et al. Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'. Int J Impot Res 2000; 12: 305-311.
24. Braun M et al. KEED-erster deutschspraching validierter Fragebogen zur Erfassung der männlichen sexuallen Funktion. Aktuel Urol 1998; 29: 300-305.
25. Meuleman EJ et al. Erectile dysfunction: prevalence and effect on the quality of life; Boxmeer study. Neder Tijdschr Geneesk 2001; 145: 576-581.
26. O'Leary MP et al. A brief sexual function inventory for urology. Urology 1995; 46: 697-706.
27. Blanker MH et al. Erectile and ejaculatory dysfunction in a community-based sample of men 50 to 78 years old: prevalence, concern, and relation to sexual activity. Urology 2001; 57: 763-768.
28. Virag R, Beck-Ardilly L. Nosology, epidemiology, clinical quantification of erectile dysfunction. La Revue Med Interne 1997; 18 (Suppl 1): 10s-13s.
29. Martin-Morales A et al. Prevalence and independent risk factors for ereticle dysfunction in Spain: results of the Epidemiologia de la Disfuncion Erectil Masculina Study. J Urol 2001; 166: 569-575.
30. Panser LA et al. Sexual function of men aged 40 to 79 years: the Olmsted County Study of urinary symptoms and health status among men. J Am Geriatri Soc 1995; 43: 1107-1111.
31. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999; 281: 537-544.
32. Pinnock CB, Stapleton AM, Marshall VR. Erectile dysfunction in the community: a prevalence study. Med J Austr 1999; 171: 353-357.
33. Ergen A et al. Prevalence and correlates of erectile dysfunction in Turkey. A population-based study. Poster presented at the ESIR Congress, 2001.
34. Feldman HA et al. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study. Prev Med 2000; 30: 328-338.
35. Wabrek AJ, Burchell RC. Male sexual dysfunction associated with coronary heart disease, Arch Sex Behav 1980; 9: 69-75.
36. Sjögren K, Fugl-Meyer AR. Some factors influencing quality of sexual life after myocardial infarction. Int Rehabil Med 1983; 5: 197-201.
37. Diokno AC, Brown MB, Herzog AR. Sexual function in the elderly. Arch Intern Med 1990; 150: 197-200.
38. Wei M et al. Total cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunction. Am J Epidemiol 1994; 140: 930-937.
39. Virag R, Bouilly P, Frydman D. Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men. Lancet 1985; 1: 181-184.
40. Bruckert E, Giral P, Heshmati HM, Turpin G. Men treated with hypolipidaemic drugs complain more frequently of erectile dysfunction. J Clin Pharm Ther 1996; 21: 89-94.
41. Weinhardt LS, Carey MP. Prevalence of erectile disorder among men with diabetes mellitus: comprehensive review, methodological critique, and suggestions for future research. J Sex Res 1996; 33: 205-214.
42. Fedele D et al. Erectile dysfunction in diabetic subjects in Italy. Diabetes Care 1998; 21: 1973-1977.
43. Lundberg PO et al. Neurosexology. Eur J Neurol 2001; 8(Suppl 3): 2-24.
44. Fugl-Meyer AR, Fugl-Meyer KS, Lundberg PO. Sexual rehabilitation. In: Frommelt P. Grötzbach (eds). Neurorehabilitation. Blackwell: Oxford, 1999, pp 370-388.
45. Elliott M, Biever LS. Head injury and sexual dysfunction. Brain Injury 1996; 10: 703-717.
46. Lundberg PO et al. Neurological disorders: erectile and ejaculatory dysfunction. In: Jardin A, Wagner G, Khoury S et al (eds). Erectile Dysfunction. 1999, pp 591-646.
47. Araujo AB et al. The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massachusetts Male Aging Study. Psychosom Med 1998; 60: 458-465.
48. Mitchell JE, Popkin MK. Antidepressant drug therapy and sexual dysfunction in men: a review. J Clin Psychopharmacol 1983; 3: 76-79.
49. Stanford JL et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA 2000; 283: 354-360.
50. Catalona WJ, Carvalhal GF, Mager DE, Smith DS. Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies. J Urol 1999; 162: 433-438.
51. Siegel T et al. The development of erectile dysfunction in men treated for prostate cancer. J Urol 2001; 165: 430-435.
52. Leliefeld HHJ, Stoevelaar HJ, McDonnell J. Sexual function before and after various treatments for symptomatic benign prostatic hyperplasia. BJU Int 2002; 89: 208-213.
53. Kunelius P, Häkkinen J, Lukkarinen O. Sexual functions in patients with benign prostatic hyperplasia before and after transurethral resection of the prostate. Urology Res 1998; 26: 7-9.
54. Francisca EAE et al. Sexual function following high energy microwave thermotherapy: results of a randomized controlled study comparing transurethral microwave thermotherapy to transurethral prostatic resection. J Urol 1999; 161: 486-490.
55. Mutscher R et al. Transurethral water-induced thermotherapy for the treatment of benign prostatic hyperplasia: a prospective multicenter clinical trial. J Urol 2000; 164: 1565-1569.
56. Slag MF et al. Impotence in medical clinic outpatients. JAMA 1983; 249: 1736-1740.
57. O'Keefe M, Hunt DK. Assessment and treatment of impotence. Med Clini North Am 1995; 79: 415-434.
58. Derby CA, Barbour MM, Hume AL, McKinlay JB. Drug therapy and prevalence of erectile dysfunction in the Massachusetts Male Aging Study cohort. Pharmacotherapy 2001; 21: 676-683.
59. Benet AE, Melman A. The epidemiology of erectile dysfunction. Urol Clini North Am 1995; 22: 699-709.
60. Kim YC et al. Endocrine and metabolic aspect in including treatment. In: Jardin A, Wagner G, Khoury S et al. (eds). Erectile Dysfunction, Plymbridge Distributor Ltd, Plymouth, United Kingdom, 1999; pp 205-240.
61. Rhoden EL et al. Is there any relation between serum levels of total testosterone and the severity of erectile dysfunction? Int J Impot Res 2002; 14: 167-171.
62. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association, 1994.
63. Fugl-Meyer KS, Fugl-Meyer AR. Sexual dysfunctions are not singularities. Int J Impot Res 2002. (Submitted).
64. Morales A, Choi H, Giami A et al. Socio-cultural, educational and ethical aspects of erectile dysfunction. In: Jardin A, Wagner G, Khoury S et al. (eds). Erectile Dysfunction, Plymbridge Distributor Ltd, Plymouth, United Kingdom, 1999; pp 575-590.
65. Ansong KS, Lewis C, Jenkins P, Bell J. Help-seeking decisions among men with impotence. Urology 1998; 52: 834-837.
66. Chew KK et al. Erectile dysfunction in general medicine practice: prevalence and clinical correlates. Int J Impot Res 2000; 12: 41-45.
67. Alonso Sandoica E et al. Impotence in diabetics: its prevalence and social-health implications. Atención Primaria 1997; 20: 435-439.
68. Skaer TL, Sclar DA, Robinson LM, Galin RS. Trends in the rate of self-report and diagnosis of ereticle dysfunction in the United States 1990-1998. Dis Manage Health Outcomes 2001; 9: 33-41.